[Lys(40)((68)Ga-DOTA)]Exendin-3

N/A

Report date: 2025/11/20 16:04:39

NME

Base Information

Drug Name[Lys(40)((68)Ga-DOTA)]Exendin-3

Drug Alias Name[Lys(40)((68)Ga-DOTA)]Exendin-3

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionGlucagon-like peptide 1 receptor agonists

TargetsGlucagon-like peptide 1 receptor

Therapy Area/IndicationsInsulinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRadboud University

China Registration ClassN/A

Develop Information

Active CompaniesRadboud University

Inactive CompaniesN/A

Active IndicationsInsulinoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A